Pharma giant Merck has signed an all-cash deal worth around $780 million to acquire Exelead, an Indiana-based biopharmaceutical contract development and manufacturing organization (biopharma CDMO). Exelead is said to have specialization in complex injectable formulations, which include Lipid Nanoparticle (LNP) based drug delivery technology. According to Merck, LNP-based technology is important in mRNA therapeutics for […]
Philip Morris International (PMI) has wrapped up its previously announced DKK 5.1 billion ($820 million) acquisition of Fertin Pharma, a Danish a specialist contract development and manufacturing organization (CDMO), from EQT Mid Market. The deal was announced in July 2021. Founded by the Bagger-Sørensen family, Fertin Pharma develops and manufactures pharmaceutical and well-being products based […]
Cipla Limited has entered into a joint venture (JV) agreement with Kemwell Biopharma, a Bengaluru-based biopharma contract development and manufacturing organization (CDMO), for developing, manufacturing, and commercializing biosimilars for global markets. The Indian pharma company said that a joint venture company will be incorporated in this connection with an objective to foray into the respiratory […]
Swiss private equity firm Partners Group has agreed on behalf of its clients to acquire a majority stake in Pharmathen, a Netherlands-based pharma company, from BC Partners, at an enterprise value of nearly €1.6 billion. Funds advised by BC Partners had acquired Pharmathen in 2015 for €475m. Established in 1969, Pharmathen operates as a contract […]
Danaher Corporation has agreed to acquire Aldevron, a North Dakota-based manufacturer of plasmid DNA, mRNA, and recombinant proteins, for nearly $9.6 billion from EQT Group’s EQT VIII fund (EQT Private Equity) and others. EQT Private Equity had acquired a majority stake in Aldevron in 2019, investing alongside TA Associates, the latter’s founders, and management. The […]
Fujifilm has selected Holly Springs of North Carolina as the location for its new $2 billion cell culture manufacturing facility in the US. In January 2021, the Japanese conglomerate announced setting up such a facility with an aim to fast-track the growth of its biopharmaceutical contract development and manufacturing business (CDMO). The end-to-end cell culture […]
Swedish private equity company EQT Partners has offered to takeover Recipharm, a Swedish pharma contract development and manufacturing organization (CDMO), for SEK 23.6 billion ($2.82 billion). As per the terms of the offer, Recipharm’s shareholders are being offered SEK 220 ($26.3) in cash for each of its class B shares EQT IX, a fund managed […]
Novavax has signed an agreement with FUJIFILM Diosynth Biotechnologies (FDB), a US-based contract development and manufacturing organization (CDMO), for the manufacturing of bulk drug substance for NVX-CoV2373, the former’s COVID-19 vaccine candidate. FUJIFILM Diosynth Biotechnologies’ facility in Morrisville, North Carolina has started production of the first batch of NVX-CoV2373. The arrangement between the two firms […]
The Carlyle Group has signed a deal worth around $490 million with Piramal Enterprises, to acquire a stake of 20% from the Indian conglomerate’s pharma business – Piramal Pharma. The US-based private equity firm will carry out the acquisition through CA Clover Intermediate II Investments, an affiliated entity of CAP V Mauritius, which is an […]
Piramal Pharma Solutions has agreed to acquire the solid oral dosage drug product manufacturing facility of G&W Laboratories in Sellersville, Pennsylvania for an undisclosed price. A subsidiary of India-based conglomerate Piramal Enterprises, the company is a contract development and manufacturing organization (CDMO), which provides end-to-end development and manufacturing solutions across the drug life cycle. According […]